北京建创奇益生物科技有限公司
fdgsa.cn
LaunchIndex first observed 北京建创奇益生物科技有限公司 (fdgsa.cn) live on 27 September 2026. View its launch screenshot, category, and verification evidence.
A launch record built from evidence.
北京建创奇益生物科技有限公司 (fdgsa.cn) was first observed live on 27 September 2026.
Beijing Jianchuangqi Bio Tech Co., Ltd. provides software development, AI application software development, information system integration, data processing, market research, management consulting, and other technology services in Beijing.
Its profile is classified as Professional service within Technology / Developer tools.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- www.fdgsa.cn
- Category
- Technology / Developer tools
- Website type
- Professional service
- Observed title
- 北京建创奇益生物科技有限公司
- Observed description
- 北京建创奇益生物科技有限公司 (http://www.fdgsa.cn)企业位于北京市昌平区回龙观镇二拨子村东北京和悦宾馆有限公司B101,经营范围是一般项目：技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；软件开发；人工智能应用软件开发；信息系统集成服务；计算机系统服务；组织文化艺术交流活动；会议及展览服务；市场营销策划；社会经济咨询服务；数据处理服务；市场调查（不含涉外调查）；企业管理咨询；信息咨询服务（不含许可类信息咨询服务）；专业设计服务；计算机软硬件及辅助设备零售；电子产品销售；互联网数据服务；网络技术服务；健康咨询服务（不含诊疗服务）；中医养生保健服务（非医疗）；远程健康管理服务；体育健康服务；养生保健服务（非医疗）；医学研究和试验发展；细胞技术研发和应用；工程和技术研究和试验发展；工程和技术研究和试验发展（除人体干细胞、基因诊断与治疗技术开发和应用，中国稀有和特有的珍贵优良品种）；农业科学研究和试验发展；自然科学研究和试验发展；发酵过程优化技术研发；生物基材料技术研发；海洋生物活性物质提取、纯化、合成技术研发；生物农药技术研发；生物有机肥料研发；生物质液体燃料生产工艺研发；生物化工产品技术研发；第一类医疗器械销售；第二类医疗器械销售。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：医疗服
- Detected technologies
- None detected
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 90%
- HTTP status
- 200
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.